BIOMODAL LIMITED
Get an alert when BIOMODAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£20M
-50.6% vs 2023
Net assets
£28M
-39.2% vs 2023
Employees
104
+15.6% vs 2023
Profit before tax
-£21M
-7.5% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £599,146 | £3,309,701 | +452.4% | |
| Operating profit | -£19,798,691 | -£21,120,722 | -6.7% | |
| Profit before tax | -£19,242,490 | -£20,681,886 | -7.5% | |
| Net profit | -£17,373,683 | -£19,002,019 | -9.4% | |
| Cash | £40,506,453 | £19,995,079 | -50.6% | |
| Total assets less current liabilities | £47,643,130 | £28,971,918 | -39.2% | |
| Net assets | £46,708,258 | £28,414,755 | -39.2% | |
| Equity | £46,708,258 | £28,414,755 | -39.2% | |
| Average employees | 90 | 104 | +15.6% | |
| Wages | £8,132,679 | £10,067,457 | +23.8% | |
| Directors' remuneration | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | -41.6% | -72.9% | |
| Gearing (liabilities / total assets) | 8.8% | 10.7% | |
| Current ratio | 12.87x | 8.66x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- BIOMODAL LIMITED 2023-12-21 → present
- CAMBRIDGE EPIGENETIX LIMITED 2012-04-20 → 2023-12-21
- NEWINCCO 1171 LIMITED 2012-03-26 → 2012-04-20
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The group meets its day-to-day working capital requirements through the cash it holds. The Group had cash and cash equivalents of £20.0m at 31 December 2024, and in July 2025 confirmed further committed funding of $28.7m through the first close of an equity financing round. The directors have a reasonable expectation that the Company has adequate resources to meet all its liabilities as they fall due and continue in operation for at least a period of 12 months from signing the financial statements and therefore consider that it remains appropriate for the going concern basis to be adopted in preparing these financial statements.”
Group structure
- BIOMODAL LIMITED · parent
- biomodal, Inc 100%
Significant events
- “On 24 July 2025, the company entered a binding agreement for a Series E equity funding round of which $28.7 million is in respect of the first close.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| STEWART, Fiona | Secretary | 2020-07-30 | — | — |
| BALASUBRAMANIAN, Shankar, Prof Sir | Director | 2012-04-20 | Sep 1966 | British,Indian |
| FROMEN, Peter John | Director | 2022-07-18 | Dec 1974 | American |
| HULME, Thomas William | Director | 2015-12-18 | Jun 1976 | British |
| MARCUS, Gail | Director | 2018-09-20 | Jun 1956 | American |
| OSTADAN, Omead | Director | 2022-07-20 | Nov 1971 | American |
| WRIGHTON-SMITH, Peter James | Director | 2023-10-25 | Sep 1974 | British |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BREAM, Peter Edward | Secretary | 2019-03-14 | 2019-11-15 |
| OLSWANG COSEC LIMITED | Corporate Secretary | 2012-03-26 | 2012-04-20 |
| BOBANOVIC, Fedja | Director | 2014-04-07 | 2015-09-21 |
| MACKIE, Christopher Alan | Director | 2012-03-26 | 2012-04-20 |
| MELLAD, Jason Alexander, Dr | Director | 2017-01-03 | 2018-11-15 |
| MURPHY, Martin Patrick, Dr | Director | 2012-08-08 | 2018-04-30 |
| NEWCOMBE-ELLIS, Alice Vanessa Ilse | Director | 2018-04-18 | 2023-02-02 |
| RINK, Timothy James, Dr | Director | 2015-01-22 | 2020-07-31 |
| SHIRODKAR, Suman Manohar, Dr | Director | 2018-11-15 | 2020-08-01 |
| SMITH, Geoffrey Paul | Director | 2016-02-22 | 2017-01-16 |
| SUBRAMANIAM, Somasundaram | Director | 2014-08-02 | 2023-02-02 |
| THOMAS, Iain Paul, Dr | Director | 2012-05-18 | 2015-01-22 |
| YERRAMILLI-RAO, Bobby Satyadev, Dr | Director | 2012-04-20 | 2023-01-20 |
| OLSWANG DIRECTORS 1 LIMITED | Corporate Director | 2012-03-26 | 2012-04-20 |
| OLSWANG DIRECTORS 2 LIMITED | Corporate Director | 2012-03-26 | 2012-04-20 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 138 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-09-09 MA Memorandum articles
- 2025-09-09 RESOLUTIONS Resolution
- 2023-12-21 CERTNM Certificate change of name company PDF
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-12 | RP01SH01 | miscellaneous | Legacy | |
| 2026-05-12 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-05-12 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2026-04-17 | SH01 | capital | Capital allotment shares | |
| 2026-04-13 | SH01 | capital | Capital allotment shares | |
| 2025-10-01 | AA | accounts | Accounts with accounts type group | |
| 2025-09-09 | SH08 | capital | Capital name of class of shares | |
| 2025-09-09 | SH08 | capital | Capital name of class of shares | |
| 2025-09-09 | MA | incorporation | Memorandum articles | |
| 2025-09-09 | RESOLUTIONS | resolution | Resolution | |
| 2025-09-08 | SH01 | capital | Capital allotment shares | |
| 2025-04-02 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-04-02 | CH01 | officers | Change person director company with change date | |
| 2025-04-02 | CH01 | officers | Change person director company with change date | |
| 2025-02-24 | SH01 | capital | Capital allotment shares | |
| 2024-09-30 | AA | accounts | Accounts with accounts type group | |
| 2024-07-12 | SH01 | capital | Capital allotment shares | |
| 2024-04-05 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-01-11 | SH01 | capital | Capital allotment shares | |
| 2023-12-21 | CERTNM | change-of-name | Certificate change of name company |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 11
- Capital events
- 7
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.